Ramez N. Eskander, MD Appointed Clinical Trials Office (CTO) Director for Oncology at UC San Diego Health Oncology and Moores Cancer Center

We are delighted to announce the appointment of Ramez N. Eskander, MD as the CTO Directorat UC San Diego Health and Moores Cancer Center. Dr. Eskander, who advances oncology through innovative gynecology oncology research, will lead CTO into a new era of discovery and patient care. CTO extends its heartfelt gratitude to Sandip Patel, MD, Dr. Eskander’spredecessor, for his contributions that laid a solid foundation for the advancement of clinical trials at Moores.

In his role as CTO Director, Dr. Eskander will work closely with Moores Associate Director of Clinical Research, Dr. Rana McKay and Moores Physician-in-Chief, Dr. Ayad Hamdan, in directing the disease-team-based clinical research portfolios at CTO.

“Dr. Eskander’s wealth of experience and knack for collaboration make him a strong leader, and CTO is confident that his tenure will further enhance its capacity to pioneer groundbreaking treatments that bolster the position of Moores as a leading cancer center in the United States” said Rana R. McKay, MD, Interim Associate Director of Clinical Research of Moores Cancer Center at UC San Diego Health. As clinical trials are instrumental in shaping the future of oncology, CTO anticipates even greater strides in translating research into tangible improvements in patient outcomes at Moores, under the guidance of Dr. Eskander. 

As CTO welcomes Dr. Eskander, Moores can celebrate the collaborative spirit that drives its mission to bring hope and healing to those battling cancer. Congratulations to Ramez, we are very excited about the transformative effect he will have on clinical trials at Moores.

About Moores Cancer Center  

Established in 1978, the UC San Diego, Moores Cancer Center is not only one of just 53 National Cancer Institute (NCI) designated Comprehensive Cancer Centers in the United States, but also the only one operating in the San Diego region. Moores Cancer Center delivers discoveries from the laboratories of UC San Diego, La Jolla Institute for Immunology, and San Diego State University, through the highly ranked cancer services of UC San Diego Health. Studies show that outcomes are better at NCI-designated Comprehensive Cancer Centers. Indeed, the cancer services of UC San Diego Health have been ranked #1 in San Diego, with 10 specialties ranking nationally, by U.S. News & World Report, as reported in its 2022–2023 "Best Hospitals" survey.